Personalized tapering of tumor necrosis factor inhibitor in axial spondyloarthritis.

Huang, Jin-Xian; Lee, Yung-Heng; Leong, Pui-Ying; Wei, James Cheng-Chung

Huang, Jin-Xian; Lee, Yung-Heng; Leong, Pui-Ying; Wei, James Cheng-Chung.

Afiliação

Huang JX; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Lee YH; Department of senior services industry management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
Leong PY; Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
Wei JC; Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.

Int J Rheum Dis ; 27(1): e15008, 2024 Jan.

Article em En | MEDLINE | ID: mdl-38140850

Assuntos

Antirreumáticos; Espondiloartrite Axial; Espondilartrite; Espondilite Anquilosante; Humanos; Inibidores do Fator de Necrose Tumoral/efeitos adversos; Antirreumáticos/efeitos adversos; Adalimumab/uso terapêutico; Espondilartrite/diagnóstico; Espondilartrite/tratamento farmacológico; Fator de Necrose Tumoral alfa; Espondilite Anquilosante/diagnóstico; Espondilite Anquilosante/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Espondilartrite / Espondiloartrite Axial Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google